Literature DB >> 25365479

Neoplasms misdiagnosed as "chronic lyme disease".

Christina Nelson1, Sarah Elmendorf2, Paul Mead1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25365479     DOI： 10.1001/jamainternmed.2014.5426

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

Review 1.  Persistent Symptoms After Treatment of Lyme Disease.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

2.  Lyme Disease Serology.

Authors:  Paul M Lantos; Paul G Auwaerter; Christina A Nelson
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

3.  The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China.

Authors:  Jianlin Xu; Guozheng Ding; Xueyan Zhang; Bo Jin; Yuqing Lou; Yanwei Zhang; Huiming Wang; Dan Wu; Baohui Han
Journal:  Onco Targets Ther       Date:  2016-10-20       Impact factor: 4.147

4.  Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United States.

Authors:  Natalie S Marzec; Christina Nelson; Paul Ravi Waldron; Brian G Blackburn; Syed Hosain; Tara Greenhow; Gary M Green; Catherine Lomen-Hoerth; Marjorie Golden; Paul S Mead
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-06-16       Impact factor: 17.586

5.  Neurological Pain, Psychological Symptoms, and Diagnostic Struggles among Patients with Tick-Borne Diseases.

Authors:  Sarah P Maxwell; Chris Brooks; Connie L McNeely; Kevin C Thomas
Journal:  Healthcare (Basel)       Date:  2022-06-23

Review 6.  Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.

Authors:  Andrew Moore; Christina Nelson; Claudia Molins; Paul Mead; Martin Schriefer
Journal:  Emerg Infect Dis       Date:  2016-07       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.